<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-vaccines-08-00115">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Coen</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Kosz-Vnenchak</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Jacobson</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Leib</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Bogard</surname>
    <given-names>C.L.</given-names>
   </name>
   <name>
    <surname>Schaffer</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Tyler</surname>
    <given-names>K.L.</given-names>
   </name>
   <name>
    <surname>Knipe</surname>
    <given-names>D.M.</given-names>
   </name>
  </person-group>
  <article-title>Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>1989</year>
  <volume>86</volume>
  <fpage>4736</fpage>
  <lpage>4740</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.86.12.4736</pub-id>
  <pub-id pub-id-type="pmid">2543985</pub-id>
 </element-citation>
</ref>
